We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
Will your humanoid robot compliment you? And the end of 23andMe?
2025/3/28
The Times Tech Podcast
The episode explores the rise and fall of 23andMe, a once-prominent biotech startup. Discussion focuses on its business model, market challenges, and leadership under Ann Wojcicki, as well as the implications of its bankruptcy on consumer genetic testing.
- 23andMe was a high-flying biotech startup from Silicon Valley that filed for bankruptcy.
- The company was founded by Ann Wojcicki, who was part of a Silicon Valley tech dynasty.
- Its business model centered on consumer genetic testing, which faced market limitations.
- The company attempted a SPAC deal and partnered with GSK for drug discovery, but these efforts did not save it.
- There are concerns about the future of the genetic data collected by 23andMe.
- Ann Wojcicki plans to bid for the company out of bankruptcy, indicating her continued belief in its potential.
Shownotes Transcript